Tiziana Life Sciences Ltd. Common Shares (TLSA)
Tiziana Life Sciences Ltd. is a biotechnology company focused on developing therapies for serious diseases, including cancer, inflammatory, and autoimmune disorders. The company leverages novel monoclonal antibody and small molecule platforms to advance clinical and preclinical candidates through its research and development pipeline. Headquartered in the UK, Tiziana Life Sciences aims to address unmet medical needs with innovative treatments.
Company News
Tiziana Life Sciences, a biotechnology company, announced that its CEO will present at the 37th Annual ROTH Conference. The company's lead development candidate, intranasal foralumab, a fully human anti-CD3 monoclonal antibody, has shown promising results in an open-label expanded access program and is currently being studied in a Phase 2a trial ...
Tesla's last earnings call sounded like a sci-fi novel but does the stock's chart signal a buy?
Oracle Corp (NYSE: ORCL) co-founder and Executive Chairman Larry Ellison recently made a surprising reveal during his CloudWorld talk. What Happened: Ellison unveiled plans for Oracle's next-generation police vehicle — and it's set to be a Tesla Inc (NASDAQ: TLSA) Cybertruck. Ellison expressed his enthusiasm for the Cybertruck, highlighting t...
Nvidia was the subject of two bullish analyst notes on Tuesday.
Will a lower price attract more investors? The answer is surprising.